Article Details

Amgen Q4 Report: Five Halted or Killed Cancer Programs, Revenue Up 7%

Retrieved on: 2021-02-03 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

Amgen Q4 Report: Five Halted or Killed Cancer Programs, Revenue Up 7%. View article details on hiswai:

Excerpt

BiTE is a class of artificial bispecific monoclonal antibodies. They direct the body's immune system, specifically the cytotoxic activity of T cells, against ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo